散发性非侵袭性甲状腺髓样肿瘤:一种无促纤维增生、单灶、无转移、经甲状腺半切除术治愈的肿瘤
本研究回顾性分析2017年1月至2022年12月单中心25例高降钙素血症散发性甲状腺髓样癌患者,其中19例冰冻切片促纤维增生阴性、6例阳性。促纤维增生阴性者多行甲状腺半切除加同侧中央颈清扫,均获得并维持生化治愈,作者提出「散发性非侵袭性甲状腺髓样肿瘤(SNMTP)」这一命名。
要点
- 促纤维增生阴性者行甲状腺半切除加同侧中央颈清扫,全部获得并维持生化治愈。
- 促纤维增生阴性者无多灶(0/19 vs 2/6,P=.050)、无淋巴结阳性(0/19 vs 6/6,P<.001)。
- 促纤维增生阴性者清扫淋巴结中位数6枚,少于阳性者的31枚(P<.001)。
核心结论
- 甲状腺半切除联合诊断性同侧中央颈清扫是促纤维增生阴性、淋巴结阴性、无转移单灶肿瘤的可行风险降低且可治愈策略,作者提出「散发性非侵袭性甲状腺髓样肿瘤(SNMTP)」命名。
研究设计与样本
- 回顾性评估2017年1月至2022年12月单中心因高降钙素血症散发性甲状腺髓样癌接受初次颈部手术的患者数据。
- 共25例患者,冰冻切片促纤维增生阴性19例、阳性6例。
主要发现
- 促纤维增生阴性者接受的手术范围更小、清扫淋巴结更少(中位数6 vs 31枚,P<.001)。
- 促纤维增生阴性者以甲状腺半切除加同侧中央颈清扫为主。
- 促纤维增生阴性者无多灶肿瘤(0/19 vs 2/6,0% vs 33%,P=.050)。
- 促纤维增生阴性者无淋巴结阳性(0/19 vs 6/6,0% vs 100%;淋巴结转移中位数0 vs 3.5枚;均P<.001)。
- 尽管手术范围有限,全部促纤维增生阴性患者获得并维持生化治愈。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The absence of primary tumor desmoplasia, a marker of node metastases, on frozen section may help reduce the extent of surgery without compromising the biochemical cure. We aimed to clarify whether hemithyroidectomy with diagnostic ipsilateral central neck dissection can replace total thyroidectomy with routine central neck dissection in patients with sporadic medullary thyroid cancer. METHODS: We retrospectively evaluated data collected from patients who had undergone primary neck surgery for hypercalcitoninemic sporadic medullary thyroid cancer between January 2017 and December 2022 at one institution. RESULTS: Of the 25 patients we examined, 19 had desmoplasia-negative and 6 desmoplasia-positive primary thyroid tumors on frozen section. The desmoplasia-negative patients had undergone less surgery with fewer nodes removed than the desmoplasia-positive patients (medians of 6 vs 31 nodes, P < .001). The desmoplasia-negative patients had predominantly undergone hemithyroidectomy with ipsilateral central neck dissection. None of the desmoplasia-negative tumors was multifocal (0 of 19 desmoplasia-negative vs 2 of 6 desmoplasia-positive or 0% vs 33%, P = .050) or node-positive (0 of 19 vs 6 of 6 patients or 0% vs 100%; medians of 0 vs 3.5 node metastases; both P < .001). Despite limited surgery, all desmoplasia-negative patients attained and maintained biochemical cure. CONCLUSION: Hemithyroidectomy combined with diagnostic ipsilateral central neck dissection is a viable risk-reducing and curative strategy for desmoplasia-negative and node-negative, nonmetastatic unifocal tumors, for which we propose the term sporadic noninvasive medullary thyroid neoplasm (SNMTP).
引用
- Dralle H, Brandenburg T, Weber F, et al. Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy. Surgery. 2023. PMID: 37821265. doi:10.1016/j.surg.2023.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。